Agenus Inc., a clinical-stage biotechnology company, discovers and develops therapies to activate your body's immune process towards most cancers and infections in the United States and internationally. It offers Retrocyte Display screen, an antibody expression platform with the identification of entirely human and humanized monoclonal antibodies;